BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $232,000 | +96.6% | 18,428 | +153.7% | 0.01% | +100.0% |
| Q1 2022 | $118,000 | +321.4% | 7,265 | +266.7% | 0.00% | +300.0% |
| Q3 2021 | $28,000 | -40.4% | 1,981 | -57.1% | 0.00% | -50.0% |
| Q1 2021 | $47,000 | +46.9% | 4,618 | +8.2% | 0.00% | +100.0% |
| Q4 2020 | $32,000 | -5.9% | 4,268 | -40.6% | 0.00% | -75.0% |
| Q2 2020 | $34,000 | +466.7% | 7,184 | +160.5% | 0.00% | +33.3% |
| Q1 2020 | $6,000 | -33.3% | 2,758 | +8.0% | 0.00% | +50.0% |
| Q4 2019 | $9,000 | -55.0% | 2,554 | +1.9% | 0.00% | -75.0% |
| Q1 2019 | $20,000 | +900.0% | 2,507 | +1153.5% | 0.01% | +700.0% |
| Q4 2018 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |